Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel

Merck KGaA (ETR:MRK) Trading 0.7% Higher - Time to Buy?

Written by MarketBeat
October 22, 2025
Merck KGaA logo with Medical background

Key Points

  • Merck KGaA's stock price increased by 0.7%, reaching a last traded price of €112.95 ($131.34) on Tuesday.
  • The company has a market capitalization of $51.12 billion and a PE ratio of 18.86.
  • Merck KGaA operates in three segments: Life Science, Healthcare, and Electronics, providing tools and chemicals for various sectors.
  • MarketBeat previews top five stocks to own in November.

Merck KGaA (ETR:MRK - Get Free Report)'s stock price traded up 0.7% on Tuesday . The stock traded as high as €113.70 ($132.21) and last traded at €112.95 ($131.34). 246,263 shares changed hands during trading, The stock had previously closed at €112.20 ($130.47).

Merck KGaA Stock Performance

The company's fifty day simple moving average is €111.29 and its two-hundred day simple moving average is €113.50. The stock has a market capitalization of $51.12 billion, a PE ratio of 18.86, a P/E/G ratio of 2.37 and a beta of 0.71.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.